Clinical trial · Interventional
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
NCT03104907CI-TRIAL-00035976completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to investigate the safety and efficacy of prostatic artery embolization of patients with recurrent symptoms secondary to locally advanced prostatic cancer including pelvic pain, bleeding or need for permanent urinary catheter who are unfit for or refuse surgical treatment.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lower Urinary Tract Symptoms | — | UNRESOLVED | — |
| Prostatic Diseases | — | UNRESOLVED | — |
| Prostatic Neoplasm | Prostate Neoplasm | ALIAS | 0.90 |
| Urological Manifestations | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Prostatic Artery Embolization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Prostatic Artery Embolization
- description
- Embolization of the prostatic arteries to induce necrosis and a reduction of the prostate volume.
- interventionNames
- Procedure: Prostatic Artery Embolization
Primary outcomes (1)
- measure
- Ability to void spontaneously
- timeFrame
- 1 months
- description
- The ability to void after removal of the indwelling catheter
Secondary outcomes (7)
- measure
- IPSS
- timeFrame
- 1, 6 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Indwelling catheter secondary to locally advanced prostate cancer (PCa) or * Moderate-severe Obstructive LUTS secondary to PCa * Unsuitable for or refuse surgery Exclusion Criteria: * Bladder dysfunction(and known neurological conditions affecting bladder function) * Urethral strictures * Bladder neck contracture * Known sphincter anomalies * Big bladder diverticulum or stones * Kidney insufficiency (eGFR \< 45) * Coagulation disturbances * Severe atheromatous or tortuosity of arteries * Allergy to contrast medium * Unable to undergo MR imaging * Bladder malignancy
References
Publications (1)
- DERIVEDMalling B, Roder MA, Lindh M, Frevert S, Brasso K, Lonn L. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series. Cardiovasc Intervent Radiol. 2019 Oct;42(10):1405-1412. doi: 10.1007/s00270-019-02227-4. Epub 2019 May 6. PMID 31062066